COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)
Public ClinicalTrials.gov record NCT04510194. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT04510194
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- University of Minnesota
- Other
- Enrollment
- 1,323 participants
Conditions and interventions
Conditions
Interventions
- Fluvoxamine Drug
- Ivermectin Drug
- Metformin Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 30 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2020
- Primary completion
- Dec 13, 2022
- Completion
- Dec 13, 2022
- Last update posted
- Apr 23, 2026
2021 – 2022
United States locations
- U.S. sites
- 7
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Olive View UCLA Medical Center | Sylmar | California | 91342 | — |
| University of Colorado Denver; Department of Medicine; Anschutz Health and Wellness Center | Aurora | Colorado | 80045 | — |
| New West Physicians | Golden | Colorado | 80401 | — |
| Northwestern University Feinberg School of Medicine | Chicago | Illinois | 60611 | — |
| American Health Network of Indiana | Greenfield | Indiana | 46140 | — |
| Hennepin County Medical Center | Minneapolis | Minnesota | 55415 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04510194, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 23, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04510194 live on ClinicalTrials.gov.